Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cells https://www.biorxiv.org/content/10.1101/2023.06.19.545595v1?med=mas
Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cells https://www.biorxiv.org/content/10.1101/2023.06.19.545595v1?med=mas